Prognostic Value of the Cumulative Cisplatin Dose During Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Secondary Analysis of a Prospective Phase III Clinical Trial

Oncologist - United States
doi 10.1634/theoncologist.2016-0105
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy: A Meta-Analysis

Cancer Management and Research
Oncology
2018English

Less Is More: Role of Additional Chemotherapy to Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Cancer Management

Radiation Oncology Journal
OncologyRadiologyNuclear MedicineImaging
2019English

Four-Year Outcome After Reduction of the Target Volume of Intensity Modulated Radiotherapy Following Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase III, Multicentre, Randomised Controlled Trial

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Cytomembranic PD-L1 Expression in Locoregionally Advanced Nasopharyngeal Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2017English

Optimal Sequencing of Chemotherapy With Chemoradiotherapy Based on TNM Stage Classification and EBV DNA in Locoregionally Advanced Nasopharyngeal Carcinoma

Cancer Communications
Cancer ResearchOncology
2019English

A Phase II Multicenter Trial of Concurrent Chemoradiotherapy With Weekly Nedaplatin in Advanced Uterine Cervical Carcinoma: Tohoku Gynecologic Cancer Unit Study

Oncology Reports
MedicineCancer ResearchOncology
2008English

Genetic Variations in Radiation and Chemotherapy Drug Action Pathways and Survival in Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Chemoradiotherapy

PLoS ONE
Multidisciplinary
2013English

Anti-Egfr Targeted Therapy Delivered Before Versus During Radiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Big-Data, Intelligence Platform-Based Analysis

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Sorafenib With or Without Concurrent Transarterial Chemoembolization in Patients With Advanced Hepatocellular Carcinoma: A Phase III STAH Trial

Journal of Hepatology
Hepatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy